Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
RPGLIFE | BSE
18.65
1.37%
Healthcare
Drug Manufacturers-Specialty & Generic
30/09/2023
08/12/2023
1,381.25
1,375.40
1,397.40
1,371.95
RPG Life Sciences Limited an integrated pharmaceutical company develops manufactures and markets branded formulations generic and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories including immunosuppressants anti-psychotic anti-anginal anthelmentics anti-convulsant anti-spasmodic etc. It also provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies such as nephrology rheumatology oncology gastroenterology cardiovascular diabetology orthopedics neuropsychiatry respiratory nutritional general urology anti-diabetic anti-dengue vitamins and minerals gynecology and pediatrics etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
View LessLow Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
Microcap (<300M USD)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
19.5%1 month
29.6%3 months
40.8%6 months
40.5%29.94
0
6.77
0
0
17.98
3.97
0
1.14B
22.64B
271.43M
0.86
21.53
29.50
13.90
24.01
0
0
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
133.85
Range1M
197.70
Range3M
388.05
Rel. volume
0.22
Price X volume
622.94K